Johnson Matthey PLC (LON:JMAT – Get Free Report) insider Liam Condon acquired 27 shares of Johnson Matthey stock in a transaction that occurred on Wednesday, March 19th. The shares were bought at an average cost of GBX 1,445 ($18.66) per share, with a total value of £390.15 ($503.74).
Liam Condon also recently made the following trade(s):
- On Wednesday, January 22nd, Liam Condon acquired 30 shares of Johnson Matthey stock. The shares were bought at an average cost of GBX 1,362 ($17.59) per share, with a total value of £408.60 ($527.57).
Johnson Matthey Stock Performance
Shares of JMAT opened at GBX 1,387 ($17.91) on Friday. The business’s fifty day simple moving average is GBX 1,423.24 and its two-hundred day simple moving average is GBX 1,457.29. The company has a current ratio of 1.45, a quick ratio of 0.76 and a debt-to-equity ratio of 62.73. Johnson Matthey PLC has a 12 month low of GBX 1,295.54 ($16.73) and a 12 month high of GBX 1,917.07 ($24.75). The company has a market cap of £2.32 billion, a price-to-earnings ratio of 23.57, a P/E/G ratio of 49,242.50 and a beta of 0.95.
Analysts Set New Price Targets
Read Our Latest Stock Report on Johnson Matthey
Johnson Matthey Company Profile
Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources.
See Also
- Five stocks we like better than Johnson Matthey
- Roth IRA Calculator: Calculate Your Potential Returns
- Why Williams-Sonoma Will Hit Fresh Highs in 2025
- What is a support level?
- Alphabet Stock Becomes a Low-Risk, High-Reward Play
- How to Profit From Value Investing
- Affirm Stock: Should You Buy the Dip After Walmart Setback?
Receive News & Ratings for Johnson Matthey Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson Matthey and related companies with MarketBeat.com's FREE daily email newsletter.